Kwality Pharmaceuticals Limited reported unaudited consolidated and standalone earnings results for the half-year ended September 30, 2018. For the period, on standalone basis, the company reported revenue from operations (Net) of INR 717.800 million against INR 615.849 million a year ago. Total revenue was INR 723.966 million against INR 619.500 million a year ago. Profit from operations before Exceptional and Extraordinary items and Tax was INR 48.559 million against INR 45.409 million a year ago. Profit before tax was INR 48.559 million against INR 45.409 million a year ago. Profit for the period was INR 36.929 million or INR 3.56 per basic and diluted share (not annualised) against INR 30.804 million or INR 5.94 per basic and diluted share (not annualised) a year ago. For the period, on consolidated basis, the company reported revenue from operations (Net) of INR 717.079 million against INR 608.352 million a year ago. Total revenue was INR 721.249 million against INR 612.516 million a year ago. Profit from operations before Exceptional and Extraordinary items and Tax was INR 47.053 million against INR 41.799 million a year ago. Profit before tax was INR 47.053 million against INR 41.799 million a year ago. Profit for the period was INR 36.161 million or INR 3.49 per basic and diluted share (not annualised) against INR 28.963 million or INR 5.58 per basic and diluted share (not annualised) a year ago.